Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplant for chronic myeloid leukemia: an attempt to define patients who may not require further therapy
Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplant for chronic myeloid leukemia: an attempt to define patients who may not require further therapy
We identified 243 patients with Ph-positive CML who had BCR-ABL transcripts monitored by quantitative RT-PCR after allogeneic stem cell transplant for a median of 84.3 months. Individual patients were regarded as having achieved molecular relapse (MR) if the BCR-ABL/ABL ratio exceeded 0.02% on three occasions or reached 0.05% on two occasions. Patients were allocated to one of four categories: (1) 36 patients were 'persistently negative' or had a single low level positive result, (2) 51 patients, 'fluctuating positive, low level', had more than one positive result but never more than two consecutive positive results; (3) 27 patients, 'persistently positive, low level', had persisting low levels of BCR-ABL transcripts but never more than three consecutive positive results, and (4) 129 patients relapsed. In 107 of these relapse was based initially only on molecular criteria; in 72 (67.3%) patients the leukemia progressed to cytogenetic or hematologic relapse either prior to or during treatment with donor lymphocyte infusions. We conclude that the pattern of BCR-ABL transcript levels after allograft is variable; only a minority of patients with fluctuating or persistent low levels of BCR-ABL transcript satisfied our definitions of MR whereas the majority of patients who did so were likely to progress further.
leukemia, therapy, blood, london, patients, cml, sct, bcr-abl transcripts, q-pcr, qr-pcr, dli
4171-4176
Kaeda, Jaspal
55cb9b4c-983a-43e8-9418-ebf91cf7354c
O'shea, Derville
7b748764-2999-4f7e-a021-670bca93615e
Szydlo, Richard M.
21106840-5ee6-4c9f-85ef-20050f83d8d4
Olavarria, Eduardo
d612c401-581b-40c3-94d2-de0826de321b
Dazzi, Francesco
67b27267-24f8-47c0-991c-35840b1dd5b1
Marin, David
b9b0f311-cb44-4c68-a68c-0e97603511e1
Saunders, Susan
4105d8a0-9470-4efc-9b0f-9b2c16ce8a8e
Khorashad, Jamshid S.
fcc14fe8-5d8e-4daf-92ee-d986a78c0f92
Cross, Nicholas C.P.
f87650da-b908-4a34-b31b-d62c5f186fe4
Goldman, John M.
2632cc83-5866-46bd-914d-8450157fe689
Apperley, Jane F.
bb44333d-1437-4eb8-876a-37332e9ffcbc
15 May 2006
Kaeda, Jaspal
55cb9b4c-983a-43e8-9418-ebf91cf7354c
O'shea, Derville
7b748764-2999-4f7e-a021-670bca93615e
Szydlo, Richard M.
21106840-5ee6-4c9f-85ef-20050f83d8d4
Olavarria, Eduardo
d612c401-581b-40c3-94d2-de0826de321b
Dazzi, Francesco
67b27267-24f8-47c0-991c-35840b1dd5b1
Marin, David
b9b0f311-cb44-4c68-a68c-0e97603511e1
Saunders, Susan
4105d8a0-9470-4efc-9b0f-9b2c16ce8a8e
Khorashad, Jamshid S.
fcc14fe8-5d8e-4daf-92ee-d986a78c0f92
Cross, Nicholas C.P.
f87650da-b908-4a34-b31b-d62c5f186fe4
Goldman, John M.
2632cc83-5866-46bd-914d-8450157fe689
Apperley, Jane F.
bb44333d-1437-4eb8-876a-37332e9ffcbc
Kaeda, Jaspal, O'shea, Derville, Szydlo, Richard M., Olavarria, Eduardo, Dazzi, Francesco, Marin, David, Saunders, Susan, Khorashad, Jamshid S., Cross, Nicholas C.P., Goldman, John M. and Apperley, Jane F.
(2006)
Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplant for chronic myeloid leukemia: an attempt to define patients who may not require further therapy.
Blood, 107 (10), .
(doi:10.1182/blood-2005-08-3320).
Abstract
We identified 243 patients with Ph-positive CML who had BCR-ABL transcripts monitored by quantitative RT-PCR after allogeneic stem cell transplant for a median of 84.3 months. Individual patients were regarded as having achieved molecular relapse (MR) if the BCR-ABL/ABL ratio exceeded 0.02% on three occasions or reached 0.05% on two occasions. Patients were allocated to one of four categories: (1) 36 patients were 'persistently negative' or had a single low level positive result, (2) 51 patients, 'fluctuating positive, low level', had more than one positive result but never more than two consecutive positive results; (3) 27 patients, 'persistently positive, low level', had persisting low levels of BCR-ABL transcripts but never more than three consecutive positive results, and (4) 129 patients relapsed. In 107 of these relapse was based initially only on molecular criteria; in 72 (67.3%) patients the leukemia progressed to cytogenetic or hematologic relapse either prior to or during treatment with donor lymphocyte infusions. We conclude that the pattern of BCR-ABL transcript levels after allograft is variable; only a minority of patients with fluctuating or persistent low levels of BCR-ABL transcript satisfied our definitions of MR whereas the majority of patients who did so were likely to progress further.
This record has no associated files available for download.
More information
Published date: 15 May 2006
Keywords:
leukemia, therapy, blood, london, patients, cml, sct, bcr-abl transcripts, q-pcr, qr-pcr, dli
Identifiers
Local EPrints ID: 59902
URI: http://eprints.soton.ac.uk/id/eprint/59902
ISSN: 0006-4971
PURE UUID: d964ae14-368e-4660-b47b-1132e5ccafdd
Catalogue record
Date deposited: 08 Sep 2008
Last modified: 16 Mar 2024 03:23
Export record
Altmetrics
Contributors
Author:
Jaspal Kaeda
Author:
Derville O'shea
Author:
Richard M. Szydlo
Author:
Eduardo Olavarria
Author:
Francesco Dazzi
Author:
David Marin
Author:
Susan Saunders
Author:
Jamshid S. Khorashad
Author:
John M. Goldman
Author:
Jane F. Apperley
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics